Nexium, Prilosec Side Effects Linked to C. Diff Diarrhea: Study

The findings of a new study suggest that side effects of Nexium, Prilosec and similar heartburn drugs may increase the risk of dangerous and sometimes deadly bouts of diarrhea. 

According to research published in this month’s issue of the American Journal of Gastroenterology, use of medications from the popular class of drugs known as proton pump inhibitors (PPIs) were associated with an increased risk of clostridium difficile-associated diarrhea (CDAD), echoing an FDA warning issued earlier this year.

The study looked at other research between 1990 and 2010, conducting a meta-analysis that encompassed 23 studies and nearly 300,000 patients. They found that patients who used Nexium, Prilosec or other PPIs were 69% more likely to be diagnosed with CDAD.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Researchers determined that there was sufficient evidence to suggest that heartburn drugs like Nexium increase the incidence of C. Diff diarrhea, leading to recommendations that people should be more cautious in using the medications to prevent gastric ulcers. They also called for the establishment of guidelines on PPI use and further studies.

In February 2012, the FDA alerted health care workers that patients who experience diarrhea while taking Nexium, Prilosec or another PPI, which does not improve, could be suffering from CDAD and said that new warning labels for all PPIs were in development.

Symptoms of C. diff-associated diarrhea from the medications may include:

  • Diarrhea that does not improve
  • Watery stool
  • Abdominal pain
  • Fever

In some cases, C. diff diarrhea can develop into more severe intestinal problems. It is caused by the bacterium known as Clostridium difficile (C. difficile) which is often associated with hospital infections.

PPIs reduce the amount of acid in the stomach and are used to treat gastroesophageal reflux disease (GERD), as well as heartburn, ulcers in the stomach and small intestines, as well as inflammation of the esophagus. Drugs that belong to the class include AcipHex, Dexilant, Nexium, Prevacid, Prilosec (and generic omeprazole), Protonix, Vimovo and Zegerid.

1 Comments

  • CarrieDecember 16, 2021 at 11:47 am

    I just was in hospital for second time with c- diff and I have a acid reflex (Gerd) diagnosed in 2007 and been taking prilosec and nexium to treat it. In 2011 was the first time I was put in hospital with c-diff and then just recently in Dec 2021 I just seen my doctor and he said quit taking anything for gerd because it’s linked to c-diff. I have not had this much pain in my stomach and this sick [Show More]I just was in hospital for second time with c- diff and I have a acid reflex (Gerd) diagnosed in 2007 and been taking prilosec and nexium to treat it. In 2011 was the first time I was put in hospital with c-diff and then just recently in Dec 2021 I just seen my doctor and he said quit taking anything for gerd because it’s linked to c-diff. I have not had this much pain in my stomach and this sick for along time. Please help me thank you.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted yesterday)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.